Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Q32 Bio (QTTB) Other Accumulated Expenses (2017 - 2023)

Historic Other Accumulated Expenses for Q32 Bio (QTTB) over the last 7 years, with Q4 2023 value amounting to $325000.0.

  • Q32 Bio's Other Accumulated Expenses fell 9655.98% to $325000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $325000.0, marking a year-over-year decrease of 9655.98%. This contributed to the annual value of $325000.0 for FY2023, which is 9655.98% down from last year.
  • Q32 Bio's Other Accumulated Expenses amounted to $325000.0 in Q4 2023, which was down 9655.98% from $8.2 million recorded in Q3 2023.
  • Q32 Bio's 5-year Other Accumulated Expenses high stood at $12.6 million for Q2 2023, and its period low was $325000.0 during Q4 2023.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $2.6 million (2021), whereas its average is $4.5 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 83133.33% in 2019, then plummeted by 9655.98% in 2023.
  • Q32 Bio's Other Accumulated Expenses (Quarter) stood at $2.3 million in 2019, then grew by 5.98% to $2.4 million in 2020, then fell by 8.36% to $2.2 million in 2021, then soared by 330.78% to $9.4 million in 2022, then crashed by 96.56% to $325000.0 in 2023.
  • Its Other Accumulated Expenses stands at $325000.0 for Q4 2023, versus $8.2 million for Q3 2023 and $12.6 million for Q2 2023.